Full Text | PDF

Share on tweeters Share on facebook Share on linkedin Share on googleplus

J Cancer 2020; 11(18):5379-5389. doi:10.7150/jca.45871 This issue Cite

Research Paper

MicroRNA-154-5p regulates the HPV16 E7-pRb pathway in Cervical Carcinogenesis by targeting CUL2

Weihong Zhao1, Yatao Liu1, Lili Zhang1, Ling Ding2, Yaqin Li1, Honglei Zhang1, Tong Wang2✉, Min Hao1✉

1. Department of Obstetrics and Gynecology, the Second Hospital of Shanxi Medical University, Taiyuan 030001, China.
2. Department of Health Statistics, School of Public Health, Shanxi Medical University, Taiyuan, Shanxi, 030001, China.

✉ Corresponding authors: Tong Wang, Department of Health Statistics, School of Public Health, Shanxi Medical University, No. 86 Xinjiannanlu Street, Taiyuan 030001, China; Tel: +86 3515 4066; E-mail: tongwangedu.cn. Min Hao, Department of Obstet More

Citation:
Zhao W, Liu Y, Zhang L, Ding L, Li Y, Zhang H, Wang T, Hao M. MicroRNA-154-5p regulates the HPV16 E7-pRb pathway in Cervical Carcinogenesis by targeting CUL2. J Cancer 2020; 11(18):5379-5389. doi:10.7150/jca.45871. https://www.jcancer.org/v11p5379.htm
Other styles

File import instruction

Abstract

Cervical cancer, induced by persistent HPV infection, has a high mortality rate. The E3 ubiquitin ligase Cullin 2 (CUL2) is critical for HPV16 E7-mediated degradation of retinoblastoma protein (pRb). Dysregulation of microRNAs (miRNAs) is induced during tumorigenesis; however, the association between miRNA networks and CUL2, specific to cervical cancer, remains unknown. Herein, we determined miRNA profiles in cervical cancer tissues using an Affymetrix miRNA array. We found that miR-154-5p was downregulated during cancer progression using real-time quantitative reverse transcription PCR in 130 biopsy specimens. Bioinformatics analysis and dual-luciferase reporter assays indicated that miR-154-5p directly targets the CUL2 3'UTR. To determine the functional consequences of modulating miR-154-5p and CUL2 levels, HPV16-positive cervical cancer cell line (SiHa) was transfected with miR-154-5p mimic, miR-154-5p inhibitor, or CUL2 siRNA. The proliferation, migration, and invasion of transfected cells were evaluated using CCK8 cell counting kit, wound-healing assay, and Transwell invasion assay. Increased miR-154-5p expression promoted significantly reduced SiHa cell proliferation, migration, and invasion, whereas the miR-154-5p inhibitor had the opposite effect. CUL2 silencing had similar effects to those of the miR-154-5p mimic. Consistent with the inverse correlation between miR-154-5p and CUL2 levels, CUL2 silencing also increased pRb expression. To our knowledge, this is the first study to demonstrate that miR-154-5p regulates pRb expression by targeting CUL2 3'UTR, thereby playing a tumor-suppressive role in HPV16 E7-induced cervical carcinogenesis.

Keywords: cervical cancer, CUL2, invasion, miR-154-5p, pRb, proliferation

Citation styles

APA
Zhao, W., Liu, Y., Zhang, L., Ding, L., Li, Y., Zhang, H., Wang, T., Hao, M. (2020). MicroRNA-154-5p regulates the HPV16 E7-pRb pathway in Cervical Carcinogenesis by targeting CUL2. Journal of Cancer, 11(18), 5379-5389. https://doi.org/10.7150/jca.45871.

ACS
Zhao, W.; Liu, Y.; Zhang, L.; Ding, L.; Li, Y.; Zhang, H.; Wang, T.; Hao, M. MicroRNA-154-5p regulates the HPV16 E7-pRb pathway in Cervical Carcinogenesis by targeting CUL2. J. Cancer 2020, 11 (18), 5379-5389. DOI: 10.7150/jca.45871.

NLM
Zhao W, Liu Y, Zhang L, Ding L, Li Y, Zhang H, Wang T, Hao M. MicroRNA-154-5p regulates the HPV16 E7-pRb pathway in Cervical Carcinogenesis by targeting CUL2. J Cancer 2020; 11(18):5379-5389. doi:10.7150/jca.45871. https://www.jcancer.org/v11p5379.htm

CSE
Zhao W, Liu Y, Zhang L, Ding L, Li Y, Zhang H, Wang T, Hao M. 2020. MicroRNA-154-5p regulates the HPV16 E7-pRb pathway in Cervical Carcinogenesis by targeting CUL2. J Cancer. 11(18):5379-5389.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image

©2024 Ivyspring International Publisher. Terms of use